Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Chronic COPD.

BIBLIOGRAPHIC SOURCE(S)

  • Texas Tech University Managed Health Care Network Pharmacy & Therapeutics Committee. Chronic COPD. Conroe (TX): University of Texas Medical Branch Correctional Managed Care; 2003 Apr. 7 p. [3 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Texas Tech University Managed Health Care Network Pharmacy & Therapeutics Committee. Chronic COPD. Conroe (TX): Texas Department of Criminal Justice, University of Texas Medical Branch; 2002 Apr. 3 p.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The major recommendations are presented in the form of an algorithm: Chronic Obstructive Pulmonary Disease (COPD), (Ambulatory Subacute Treatment).

Refer to the original guideline document for classification of COPD by severity and patient education on the use of an inhaler.

CLINICAL ALGORITHM(S)

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Texas Tech University Managed Health Care Network Pharmacy & Therapeutics Committee. Chronic COPD. Conroe (TX): University of Texas Medical Branch Correctional Managed Care; 2003 Apr. 7 p. [3 references]

ADAPTATION

DATE RELEASED

1996 Sep (revised 2003 Apr)

GUIDELINE DEVELOPER(S)

University of Texas Medical Branch Correctional Managed Care - Academic Institution

SOURCE(S) OF FUNDING

University of Texas Medical Branch Correctional Managed Care

GUIDELINE COMMITTEE

Clinical Guidelines Committee on Asthma/COPD

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Committee Members: Glenda Adams, MD; Charles Adams, MD; Andrew Grant, MD; Renee Lenz, PharmD; Matthew Keith, RPh; William Givens, Resp Therapist

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Texas Tech University Managed Health Care Network Pharmacy & Therapeutics Committee. Chronic COPD. Conroe (TX): Texas Department of Criminal Justice, University of Texas Medical Branch; 2002 Apr. 3 p.

GUIDELINE AVAILABILITY

Print copies: Available from University of Texas Medical Branch (UTMB), 3009A HWY 30 West, Huntsville, TX, 77340.

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on March 12, 2003. The information was verified by the guideline developer on March 24, 2003. This summary was updated by ECRI on April 21, 2004.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo